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Abstract: Abstract: Background: The Mediterranean diet may be capable of improving cognitive
function. However, the red meat restrictions of the diet could impact long-term adherence in Western
populations. The current study therefore examined the cognitive effects of a Mediterranean diet with
additional red meat. Methods: A 24-week parallel crossover design compared a Mediterranean diet
with 2–3 weekly servings of fresh, lean pork (MedPork) and a low-fat (LF) control diet. Thirty-five
participants aged between 45 and 80 years and at risk of cardiovascular disease followed each
intervention for 8 weeks, separated by an 8-week washout period. Cognitive function was assessed
using the Cambridge Neuropsychological Test Automated Battery. Psychological well-being was
measured through the SF-36 Health Survey and mood was measured using the Profile of Mood States
(POMS). Results: During the MedPork intervention, participants consumed an average of 3 weekly
servings of fresh pork. Compared to LF, the MedPork intervention led to higher processing speed
performance (p = 0.01) and emotional role functioning (p = 0.03). No other significant differences
were observed between diets. Conclusion: Our findings indicate that a Mediterranean diet inclusive
of fresh, lean pork can be adhered to by an older non-Mediterranean population while leading to
positive cognitive outcomes.
Keywords: MedDiet; protein; cognitive function; ageing; cardiovascular disease

1. Introduction
Dementia is characterised by severe cognitive impairment and reduced quality of life. As the
population ages, the prevalence of age-related disorders like dementia is predicted to increase [1].
However, recent reports indicate that 30–35% of dementias may be preventable through risk factor
modification [2].
Modifiable risk factors for dementia include hypertension, obesity, diabetes, smoking, and physical
activity. Multi-domain interventions with the ability to improve health across these risk factors are
now being investigated for their potential to delay cognitive decline and reduce risk of dementia [3].
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The Mediterranean diet is a predominantly plant-based diet, characterised by the high consumption
of extra virgin olive oil, vegetables, fruits, nuts, seeds and whole grains; a moderate intake of fish,
poultry and dairy foods; and a low intake of red meat and processed foods [4]. The Mediterranean diet
is therefore rich in bioactive nutrients, including mono and polyunsaturated fatty acids, polyphenols,
flavanols, carotenoids, essential vitamins and fibre. Observational studies have demonstrated that
populations following a traditional Mediterranean diet experience less cognitive decline and a lowered
risk of dementia [5,6]. Similarly, clinical trials have reported that participants following a Mediterranean
dietary pattern achieve higher performance on tests sensitive to ageing and dementia compared to
those following a low-fat control diet [7–9].
The cognitive benefits of the Mediterranean diet may be due to improvements in cardiovascular
health. Clinical studies have shown that the Mediterranean diet is capable of reducing blood pressure,
inflammation and atherosclerosis [10,11]. By improving systemic blood flow, the Mediterranean diet
may be capable of increasing blood and oxygen supply to the brain, and preventing premature brain
cell death [12]. Additionally, nutrients consumed within a Mediterranean diet may have direct benefits
for brain cell function. Omega-3 polyunsaturated fatty acids are a vital component of neural membrane
growth, repair, structure and function [13]. Further, omega-3 fatty acids produce anti-inflammatory
lipid mediators in the brain, while polyphenols and flavanols may have anti-oxidant effects and protect
against oxidative stress. Omega-3 fatty acids are unable to be synthesised by the body and must be
obtained from the diet. By providing rich sources of omega-3 fatty acids such as oily fish, walnuts and
seeds, the Mediterranean diet may influence brain cell function, integrity and health [12].
The Mediterranean diet may be an appropriate lifestyle intervention in Australia, where dementia
is one of the leading causes of disability, the second leading cause of death, and the leading cause of death
in women [14]. Literature investigating the palatability of Mediterranean diets in non-Mediterranean
populations is relatively nascent. However, our research group recently reported that the red meat
restrictions of the Mediterranean diet were one of the biggest challenges to sustaining adherence [15].
A Mediterranean diet that allows additional red meat sources may therefore improve feasibility
and palatability in non-Mediterranean populations. Red meat supplementation may also provide
additional cognitive benefits to a Mediterranean dietary pattern. Protein-rich foods, such as lean red
meat, provide creatine and thiamine. Creatinine and thiamine are involved in brain energy metabolism
and homeostasis, and may influence cognitive function [16–18]. Further, diets higher in protein have
been linked to a reduced risk of dementia [16].
In Australia, beef and pork are the most frequently consumed sources of red meat [19].
In comparison to beef, fresh, lean pork contains less heme iron and less saturated fat per 100 g.
Pork may then be a suitable addition to the Mediterranean diet, which is traditionally low in heme
iron sources and saturated fat. Previous research also indicates that chicken can be replaced with
pork without negative effects on blood lipids, glucose, insulin or cognitive function [20,21]. Further,
pork production has been associated with significantly less greenhouse gas emissions compared with
ruminant meats [22]. The inclusion of pork will therefore have less of an impact on the environmental
sustainability of the dietary pattern.
As reported elsewhere, a Mediterranean diet supplemented with fresh, lean pork is comparable
to a low-fat diet for cardiovascular outcomes [23]. However, the cognitive effects of the diet are
unknown. The current study therefore examined a Mediterranean diet modified to include 2–3 fresh
servings of pork each week across measures of cognitive function and well-being. In line with previous
cardiovascular and cognitive research [7,24,25], a low-fat control was employed. It was hypothesised
that the modified Mediterranean diet would lead to greater improvements in cognitive functions
associated with ageing and dementia compared with the control diet.
2. Methods
The MedPork trial was designed to evaluate the cardiovascular and cognitive effects of a
Mediterranean diet supplemented with fresh, lean pork. The study protocol and cardiovascular
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findings have been published elsewhere [23,26]. The secondary cognitive and psychological outcomes
are presented herein.
2.1. Ethics
This trial was registered with the Australian New Zealand Clinical Trials Registry
(ACTRN12616001046493) on 5 August, 2016 and was conducted in accordance with the Declaration of
Helsinki. All procedures involving human participants were approved by the University of South
Australia Human Ethics Committee (#35662). This trial was registered with the Australian New
Zealand Clinical Trials Registry (ACTRN12616001046493) on 5th August 2016.
2.2. Participants and Recruitment
Volunteers were recruited from metropolitan Adelaide via electronic and paper advertisements.
Adults aged 45–80 years were recruited due to their increased risk of developing cardiovascular
disease (CVD) [27]. Eligible volunteers were required to have elevated systolic blood pressure (≥120
mmHg) and at least two of the following cardiovascular risk factors: Body mass index ≥ 25 kg/m2 ;
elevated fasting total cholesterol (≥5.5 mmol/L), triglycerides (≥2.0 mmol/L), low-density lipoprotein
(≥3.5mmol/L), or low levels of high-density lipoprotein (≤0.9 mmol/L for men and ≤1.0 mmol/L for
women); elevated fasting glucose (between 6.1 and 7.8 mmol/L); and/or a family history (up to one
generation) of CVD or type 2 diabetes mellitus. Volunteers were excluded if they met any of the
following criteria: Currently taking antihypertensive medication; current smoker; current CVD or
angina; current or recent (within 6 months) malignancies; respiratory disease; gastrointestinal disease;
kidney disease; type 2 diabetes mellitus; a current or previous traumatic head or brain injury; a current
neurological or psychiatric condition; antidepressant or anxiety medication; a current diagnosis of
Alzheimer’s disease or dementia; currently following a Mediterranean-style diet, as assessed by a score
of 10 or above on the Prevencionn con Dieta Mediterranea (PREDIMED) 14-point checklist [24], or
currently consuming supplemental omega-3 fatty acids >1000mg daily. Other dietary supplements
were permitted on the condition that they had been consumed for three months prior to screening and
were consumed consistently throughout the trial.
Eligibility was determined using a diet and lifestyle questionnaire and follow-up screening visit at
the Sansom Institute for Health Research Clinical Trial Facility (SIHR CTF) in Adelaide, South Australia.
2.3. Design
The current study employed a 24-week parallel crossover design to compare a Mediterranean diet
with 2-3 weekly servings of fresh, lean pork (MedPork) and a low-fat control diet (LF). A low-fat diet
was chosen as a comparator for two reasons. Firstly, at the time of study conception, low fat diets were
recommended and utilised as a strategy to prevent and treat diet-related chronic disease, such as CVD.
Secondly, the current study aimed to replicate the design of the PREDIMED trial, the largest clinical
investigation of the Mediterranean diet [24], which also employed a low-fat control diet. Participants
were randomised to their first dietary intervention using block randomization, stratified by age and
gender. Group 1 (n = 16) participants were randomised to complete the MedPork intervention followed
by the LF intervention. Group 2 (n = 17) participants were randomised to complete the LF intervention
followed by the MedPork intervention. The participants followed each diet for 8 weeks, and an 8-week
washout period separated interventions. Based on previous nutritional intervention studies, 8 weeks
was expected to be an adequate intervention period to detect change in cognitive function [28–30].
2.4. Dietary Interventions
2.4.1. Low-Fat Diet (LF)
Guidelines for the LF diet were based on the PREDIMED study [24]. During the LF intervention,
participants were advised to follow their habitual diets, making adjustments to reduce total fat
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consumption. Participants were instructed to drastically reduce their intake of high-fat foods, such
as vegetable oils (≤20mL per day), butter and margarine (≤10mL per day), high-fat meats and dairy,
nuts, chocolates, cakes and pastry, and to consume lower fat alternatives. When buying packaged or
ready-made foods, participants were advised to select products containing less than 10% of energy
from fat, excluding dairy where low-fat milk (<2% fat), yoghurt (<2% fat) and cheese (<25% fat) were
recommended. Participants were also instructed to remove visible fat and skin from meat and fish
before cooking.
2.4.2. Mediterranean Diet with Pork (MedPork)
During the MedPork intervention, participants were advised to follow a Mediterranean diet while
consuming 2–3 weekly serves of fresh, lean pork (see Supplemental Table S1). Mediterranean diet
guidelines were adapted from Estruch et al. (2013) [24] for an Australian food supply.
During the MedPork intervention, the following foods were provided each week: 375mL EVOO
(donated by Cobram Estate); 250 g of fresh, lean pork; 150 g raw, unsalted almonds (donated by
Almond Board of Australia), walnuts and hazelnuts; 225 g (net weight) of canned chickpeas, red kidney
beans, 4-bean mix and lentils (donated by Simplot Australia Pty Ltd.); 95 g of canned tuna and 95 g of
canned salmon (donated by Simplot Australia Pty Ltd.).
2.4.3. Dietetic Counselling
At the beginning of each dietary intervention, participants met with a dietitian who delivered
dietary education, guidelines and resources [26]. Throughout the dietary intervention, participants
also attended bi-weekly dietetic visits to discuss dietary adherence, challenges and adverse effects.
2.5. Measures
2.5.1. Cognitive Function
Cognitive function was assessed using the Cambridge Neuropsychological Test Automated Battery
(CANTAB). A battery of tests was selected to measure change across memory, attention, processing
speed and planning. These cognitive domains were of particular interest due to their sensitivity to
aging, cardiovascular health and nutritional intervention. Supplemental Table S2 details the tests
included to assess each cognitive domain. A motor orientation task was performed at the beginning
of each testing session, and each subsequent task contained a practice component to familiarise
participants with the CANTAB tablet.
Addenbrooke’s Cognitive Examination-Revised (ACE-R) was administered at screening to exclude
volunteers with possible mild cognitive impairment (MCI) or dementia [31], and again at Weeks 8
and 24.
2.5.2. Sleep
The Karolinska Sleep Scale (KSS) was administered prior to each cognitive testing session to gauge
the level of sleepiness, which may interfere with cognitive performance. The KSS is a 9-point scale
that asked participants to rate their current level of sleepiness where 1 = Extremely alert and 9 = Very
sleepy, great effort to keep awake, fighting sleep. If participants scored 6 or above or commented on
poor sleep quality of the previous night, cognitive testing was rescheduled.
2.5.3. Psychological Well-Being
Psychological well-being was evaluated using the SF-36 Health Survey Version II, adapted for
use in Australia [32,33], and the Profile of Mood States (POMS) [34]. For measures of psychological
well-being, participants were asked to reflect on their perceptions of their health and mood over the
previous month.
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2.5.4. Dietary Adherence
Adherence was assessed throughout the interventions using diet-specific surveys. A 15-point
survey assessed adherence to the MedPork intervention, and a 9-point survey assessed adherence to the
LF intervention. Both surveys were modelled on those used in the PREDIMED trial [24]. The surveys
were completed by participants every two weeks and returned and scored at dietetic visits. Detailed
dietary and nutrient intake was also captured prior to, and at the end of, each intervention using 3-day
weighed food records (WFRs).
2.6. Procedure
Participants attended clinic assessment visits at week 0, 8, 16 and 24. One week prior to Week 0,
participants also attended a pre-baseline appointment where the study was explained, study resources
were provided, and informed consent was obtained.
The SF-36, POMS and WFRs were completed by participants in the week preceding each assessment
visit. To limit the potential for measurement error, cognitive testing was performed under controlled
conditions [35]. Participants arrived at clinic assessment visits fasted from food, beverages (excluding
water), alcohol and caffeine for 12 h. Following cardiovascular measurements (reported elsewhere),
participants consumed a standardised continental breakfast of toast or cereal 15 min prior to cognitive
testing. Cognitive testing took place between 9:00 a.m. and 12:00 p.m. in a temperature and
noise-controlled environment. CANTAB test administration was standardised through the use of a
testing script provided by Cambridge Cognition.
Participants followed their first intervention between Week 0 and Week 8, and their second
intervention between Week 16 and Week 24. During intervention periods, participants also attended
bi-weekly dietetic visits (described above). Between Week 8 and Week 16, participants returned to
their habitual diet to wash out any effects of the first dietary intervention.
2.7. Statistical Analysis
Statistical analyses were conducted using SPSS version 21.0 (SPSS Inc, Chicago, IL, USA) and STATA
version 14.2 (StataCorp, College Station, TX, USA). Nutrient intake was calculated using Foodworks 9,
databases AusFoods17 and AusBrands17 (Xyris Software Pty Ltd., Spring Hill, Australia).
The current study was powered to detect a clinically significant reduction of 2.5 mmHg in the
primary outcome, systolic blood pressure (reported elsewhere) [26]. The study was also powered on
major secondary outcomes. To detect a statistically significant difference in cognitive composite scores
for attention, processing speed, memory and planning, assuming a correlation between measurements
of r = 0.6, and an effect size of 0.5 SD units [35,36], a total sample size of n = 22 was required for
80% power.
Cognitive composite scores were calculated by generating z-scores for each CANTAB test. Z-scores
were then combined and averaged relative to their cognitive domain: attention, memory, processing
speed or planning. For tests where a lower score indicates better performance (i.e., reaction time), raw
scores were reversed before being converted to z-scores.
Baseline characteristics were compared between groups using independent samples t-tests and
chi-squared test of independence. Preliminary linear mixed-effects analyses were conducted for all
outcomes to detect a significant period and carryover effects. Level 1 and level 2 residuals were tested
for normality. Non-normally distributed data was log-transformed using base 10.
The linear mixed-effects models included terms for diet (MedPork vs. LF), Visit (1 or 2), Order
(1 or 2) and Period (1 or 2). Visit 1 refers to week 0, and Visit 2 to week 8 of each intervention. Order
refers to whether participants followed the MedPork (Order 1) or LF (Order 2) intervention first.
Period refers to the phase of the trial in which the intervention was followed: Week 0–8 = Period 1;
Week 16–24 = Period 2. A Diet–X-Visit term was included to test the difference in the change between
Week 0 and Week 8 between interventions. Treatment effects were estimated using the difference in
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the adjusted marginal means at Visit 2 and are presented as the estimated mean difference between
interventions (MedPork versus LF). Where significant period effects were identified in preliminary
analyses, the Diet-X-Visit term was replaced by Diet-X-Visit-X-Period to allow the Diet-X-Visit effect to
vary by period. The participant ID number was included in the model as a random intercept. Missing
data were accounted for by using the best linear unbiased predictions (BLUP) of the mixed effects
models. No adjustments were performed for multiple comparisons in order to preserve the Type II
error rate.
3. Results
In the current study, 35 participants were enrolled and randomised to their first dietary
intervention. Baseline data was collected for 33 participants. A total of 31 participants completed both
dietary interventions.
Figure 1 illustrates the Consort flow of the study, detailing time of withdrawals. Following
baseline assessments, one participant withdrew during the MedPork intervention in the first period
and one participant withdrew during the washout period, prior to commencing the LF intervention.
Reasons for withdrawal included competing commitments (n = 1) and illness preventing adherence
to dietary intervention (n = 1). The results below are based on the modified intention to treat (ITT)
population (n = 33).
Baseline characteristics of participants are presented in Table 1. A significant difference was
detected at baseline for ACE-R score. No other significant differences were observed between groups.
Table 1. The demographic and clinical characteristics of the study sample at baseline, according to the
first dietary intervention 1 .

Age (years)
Gender
Males (%)
Females (%)
Education (years)
Home SBP (mmHg)
BMI (kg/m2 )
ACE-R

Total (n = 33)

Group 1 (n = 16)

Group 2 (n = 17)

61.0 ± 7.1

60.2 ± 8.7

61.6 ± 5.7

10 (30.3)
23 (69.7)
16.7 ± 4.4
128.9 ± 12.1
30.6 ± 5.1
95.1 ± 3.8

6 (40.0)
9 (60.0)
15.7 ± 3.5
129.2 ± 14.0
31.6 ± 5.7
93.7 ± 4.2

4 (22.2)
14 (77.8)
17.5 ± 4.9
128.5 ± 10.4
29.8 ± 4.6
96.4 ± 2.8 *

1

Values are presented as mean ± standard deviation Between group differences compared using independent
samples t-tests and chi-squared test of independence. Group 1 received MedPork intervention first; Group 2
received LF intervention first; SBP, systolic blood pressure, BMI, body mass index; ACE-R, Addenbrooke’s Cognitive
Examination-Revised. * Significant difference between groups at p < 0.05.

3.1. Period Effects
There were no significant Treatment-X-Visit-X-Period interactions for the cognitive composite
scores. However, a significant Treatment–X-Visit-X-Period interaction was found for total mood
disturbance using the Profile of Mood States.
3.2. Dietary Adherence and Nutrients
At screening, the mean score for the 15-point Mediterranean diet survey was 6.1 ± 2.1. During the
MedPork intervention, the mean score was 13.5 ± 1.7, indicating 90% adherence and an increase of
7.4 points from screening. During the LF intervention, participants achieved a mean score of 8.4 ± 1.1
on the 9-point low-fat survey, indicating 93.3% adherence.
Nutrient intakes across the intervention periods are presented in Table 2. According to WFRs,
participants consumed 0.4 ± 0.1 servings of fresh pork each day, or 3.0 ± 0.7 servings each week, during
the MedPork intervention.
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n = 395

Diet and lifestyle questionnaires
posted
n = 290

DLQ returned
n = 98

Ineligible volunteers

Volunteers booked for
screening

n = 27

n = 66

Eligible volunteers

Withdrawal prior to
enrolment

n = 39

n=4

Withdrawals prior to

Randomised

baseline

n = 35

n=2

Withdrawals after

MedPork

Low fat
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n = 16

n = 17
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Low fat

MedPork
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n = 14

n = 17

n=1

n=1

Completed
n = 31

Figure 1. Consort diagram illustrating the flow of the participants from recruitment through to study
completion. The intention-to-treat analysis is based on all the participants with baseline data (n= 33).
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Table 2. Energy and nutrient intakes at baseline and week 8, including between group differences (n = 33) 1.
MedPork Diet
Nutrients

Baseline
Mean

Energy (MJ/day)
% en from protein
% en from total fat
% en from SFA
% en from MUFA
% en from PUFA
MUFA:SFA 4
% en from CHO
% en from alcohol
Cholesterol (mg/MJ) 4
Fibre (g/MJ)
Vitamin C (mg/MJ) 4
Vitamin E (mg/MJ) 4
Total vit A equiv. (mg/MJ) 4
Total folate (µg/MJ)
β-carotene equiv. (mg/MJ) 4
Sodium (g/MJ)
Calcium (g/MJ)
Iron (mg/MJ) 4
Zinc (mg/MJ)
Linoleic acid (g/MJ)
α-linolenic acid (g/MJ) 4
Servings/day
Whole grains 4
Refined grains 4
Fruits
Vegetables 4
Legumes 4
Meat/meat altern.
Red meat 4
Fresh pork 4
Seafood 4
Nuts and seeds 4
Total dairy 4
EVOO (tsp/day) 4
1

SE

LF Diet

Week 8
Mean

SE

Baseline
Mean

SE

Week 8
Mean

SE

Estimated Mean Difference between
Interventions (MedPork vs LF) at 8 Weeks 2

p3

(95% CI)

8.96 ± 0.33
18.40 ± 0.65
34.08 ± 1.25
12.07 ± 0.57
5.41 ± 0.34
13.89 ± 0.76
1.24 ± 0.09
39.50 ± 1.37
4.41 ± 0.81
37.76 ± 0.34
3.03 ± 0.19
11.34 ± 0.39
1.64 ± 0.11
0.11 ± 0.01
61.65 ± 3.56
0.49 ± 0.08
0.28 ± 0.02
0.10 ± 0.01
1.48 ± 0.07
1.32 ± 0.06
1.18 ± 0.08
0.17 ± 0.01

8.33 ± 0.33
19.71 ± 0.67
36.84 ± 0.67
9.18 ± 0.58
7.61 ± 0.35
17.37 ± 0.79
1.99 ± 0.09
35.23 ± 1.37
3.45 ± 0.82
33.64 ± 3.48
3.98 ± 0.19
21.53 ± 1.56
2.14 ± 0.12
0.13 ± 0.01
68.28 ± 3.68
0.67 ± 0.08
0.24 ± 0.02
0.11 ± 0.01
1.48 ± 0.07
1.27 ± 0.06
1.69 ± 0.08
0.23 ± 0.02

9.00 ± 0.33
19.45 ± 0.66
34.59 ± 1.27
12.24 ± 0.57
5.53 ± 0.35
14.16 ± 0.077
1.19 ± 0.09
38.59 ± 1.35
3.54 ± 0.82
43.57 ± 3.44
3.06 ± 0.19
12.53 ± 1.51
1.47 ± 0.12
0.12 ± 0.01
63.94 ± 3.63
0.51 ± 0.08
0.32 ± 0.02
0.11 ± 0.01
1.39 ± 0.07
1.30 ± 0.06
1.23 ± 0.08
0.16 ± 0.02

7.86 ± 0.34
22.21 ± 0.68
27.52 ± 1.31
9.23 ± 0.59
5.05 ± 0.36
10.68 ± 0.80
1.18 ± 0.09
41.23 ± 1.39
3.99 ± 0.83
38.97 ± 3.58
3.84 ± 0.20
17.26 ± 1.58
1.40 ± 0.12
0.12 ± 0.01
81.11 ± 3.74
0.58 ± 0.08
0.28 ± 0.02
0.12 ± 0.01
1.63 ± 0.07
1.40 ± 0.06
1.11 ± 0.09
0.16 ± 0.02

0.47 (−0.32, 1.27)
−2.51 (−4.10, 0.91)
9.32 (5.91, 12.74)
−0.05 (−1.41, 1.31)
2.56 (1.61, 3.51)
6.69 (4.55, 8.83)
1.69 (1.46, 1.95)
−6.00 (−9.22, −2.79)
−0.55 (−1.75, 0.65)
0.82 (0.68, 1.01)
0.14 (−0.31, 0.59)
0.81 (0.96, 1.59)
1.57 (1.33, 1.85)
0.01(−0.01, 0.01)
−12.83 (−21.57, 4.09)
0.01 (−0.01, 0.01)
−0.04 (−0.08, 0.01)
−0.01 (−0.02, 0.01)
0.93 (0.82, 1.05)
−0.12 (−0.26, 0.01)
0.59 (0.36, 0.81)
1.49 (1.19, 1.86)

0.24
<0.01
<0.001
0.94
<0.001
<0.001
<0.001
<0.001
0.37
0.06
0.54
0.10
<0.001
0.96
<0.01
0.45
0.06
0.14
0.21
0.07
<0.001
<0.001

2.14 ± 0.26
3.61 ± 0.37
1.30 ± 0.17
4.39 ± 0.60
0.19 ± 0.09
2.71 ± 0.19
0.64 ± 0.13
0.09 ± 0.05
0.38 ± 0.08
0.47 ± 0.08
1.80 ± 0.20
1.14 ± 0.39

2.44 ± 0.27
1.96 ± 0.38
2.20 ± 0.18
5.83 ± 0.62
0.63 ± 0.09
3.43 ± 0.20
0.85 ± 0.13
0.44 ± 0.06
0.64 ± 0.08
0.96 ± 0.08
1.60 ± 0.20
4.51 ± 0.39

1.70 ± 0.26
3.84 ± 0.38
1.57 ± 0.18
3.66 ± 0.61
0.23 ± 0.09
2.95 ± 0.20
0.78 ± 0.13
0.16 ± 0.05
0.30 ± 0.08
0.50 ± 0.08
1.92 ± 0.20
1.15 ± 0.39

2.03 ± 0.27
3.45 ± 0.38
1.74 ± 0.18
5.02 ± 0.64
0.35 ± 0.09
2.62 ± 0.20
0.71 ± 0.13
0.13 ± 0.05
0.39 ± 0.08
0.22 ± 0.08
1.93 ± 0.20
0.68 ± 0.39

1.49 (0.88, 2.54)
0.65 (0.49, 0.85)
0.46 (0.05, 0.86)
1.25 (0.95, 1.62)
1.90 (1.19, 3.04)
0.81 (0.34, 1.27)
1.09 (0.95, 1.25)
1.13 (1.06, 1.20)
1.19 (1.05, 1.36)
1.61 (1.42, 1.84)
0.85 (0.64, 1.11)
2.83 (2.20, 3.65)

0.14
<0.01
0.03
0.10
<0.01
<0.001
0.24
<0.001
<0.01
<0.001
0.23
<0.001

Values are mean ± SE. 2 Estimated marginal mean difference from linear mixed effects models. Differences between interventions were analysed by linear mixed effects models, including
fixed effect terms for Group, Visit, Group X Visit, Period, Order and Weight (excluding weight-related variables). 3 Adjusted for differences between treatments. 4 Transformed variable:
Observed mean ± SE are presented together with rate ratio change in the geometric mean and associated p-value. En, energy; SFA, saturated fat; MUFA, monounsaturated fat; PUFA,
polyunsaturated fat; CHO, carbohydrates, Vit, vitamin; equiv, equivalents; altern, alternatives.

Nutrients 2019, 11, 1521

9 of 16

Compared to the LF intervention, the MedPork intervention led to a greater consumption of %
energy from fat, % energy from MUFA, % energy from PUFA and MUFA:SFA. The LF intervention led
to a significantly higher intake of % energy from protein and carbohydrates. The MedPork intervention
led to significantly fewer servings per day of refined grains, and a higher consumption of legumes,
seafood, nuts and seeds, EVOO, meat and meat alternatives, but not red meat.
3.3. Cognitive Function
The results for cognitive outcomes are presented in Table 3. No significant differences were
observed between groups for the cognitive composite scores of memory, attention, planning, or
the ACE-R. However, a significant effect was observed for processing speed, where the MedPork
intervention was associated with higher performance.
Table 3. The standardised cognitive composite scores and ACE-R at the baseline and final visit,
including between group differences (n = 33) 1 .
MedPork Diet
Baseline
Mean
Attention
Processing speed
Memory
Planning
ACE-R

SE

−0.14 ± 0.11
−0.04 ± 0.16
0.04 ± 0.09
−0.18 ± 0.11
95.98 ± 0.52

LF Diet

Week 8
Mean

SE

0.17 ± 0.11
0.13 ± 0.16
-0.08 ± 0.09
0.15 ± 0.11
96.19 ± 0.53

Baseline
Mean

SE

−0.06 ± 0.11
0.01 ± 0.16
0.03 ± 0.09
−0.05 ± 0.11
95.13 ± 0.52

Week 8
Mean

SE

0.14 ± 0.11
−0.19 ± 0.16
0.07 ± 0.09
0.09 ± 0.11
96.37 ± 0.53

Estimated Mean Difference between
Interventions (MedPork vs LF) at 8 Weeks 2

p3

(95% CI)
0.04 (−0.14, 0.21)
0.32 (0.08, 0.57)
−0.15 (−0.31, 0.01)
0.06 (−0.14, 0.26)
−0.18 (−1.12, 0.76)

0.70
0.01
0.06
0.56
0.71

1

Values are mean ± SE. 2 Estimated marginal mean difference from linear mixed effects models 3 Adjusted for
baseline differences between treatments.

3.4. Psychological Well-Being
Results for psychological well-being are reported in Table 4. Compared with the LF intervention,
the MedPork intervention led to higher scores for role emotional of the SF-36, with a moderate effect
size (d = 0.5). No significant differences were reported for the remaining outcomes of the SF-36 Health
Survey, nor for the items of the Profile of Mood States.
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Table 4. SF-36 Health Survey and Profile of Mood States at baseline and week 8, including between group differences (n = 33) 1 .
MedPork Diet

SF-36 Health Survey
Physical functioning 5
Role physical 5
Bodily pain
General health
Vitality
Social functioning 5
Role emotional 5
Mental health 5
Physical component score
Mental component score
POMS
Tension 5
Depression 5
Anger 5
Confusion 5
Fatigue 5
Vigour
Total Mood Disturbance 5
1

LF Diet

Estimated Mean Difference between
Interventions (MedPork vs LF) at 8 Weeks 3

p4

Normative Data 2

Baseline

Week 8

Baseline

Week 8

Mean (SD)

Mean + SE

Mean + SE

Mean + SE

Mean + SE

(95% CI)

92.5 (13.4)
91.4 (23.2)
86.3 (17.9)
78.8 (15.7)
64.0 (18.2)
91.3 (15.8)
85.6 (29.3)
75.4 (16.3)
-

81.57 ± 2.88
84.58 ± 3.19
71.54 ± 3.36
68.84 ± 3.39
61.45 ± 3.05
89.96 ± 2.80
93.26 ± 2.22
82.97 ±1.96
49.60 +1.34
54.92 + 1.08

85.82 ± 2.96
91.54 ± 3.35
78.66 ± 3.47
74.18 ± 3.46
65.51 ± 3.19
89.93 ± 2.97
96.87 ± 2.33
85.80 ±2.01
52.27 + 1.36
55.68 + 1.11

83.56 ± 2.96
84.88 ± 3.13
75.72 ± 3.33
71.12 ± 3.38
64.11 ± 3.02
89.64 ± 2.73
91.67 ± 2.18
83.70 ±1.92
50.98 + 1.34
55.00 + 1.08

83.47 ± 2.95
88.95 ± 3.33
74.74 ± 3.47
74.99 ± 3.45
67.89 ±3.18
91.71 ± 2.95
91.30 ± 2.32
83.61 ±1.98
51.61 + 1.37
54.40 + 1.12

0.95 (0.64, 1.38)
0.71 (0.38, 1.32)
3.92 (−1.84, 9.67)
−0.80 (−5.14, 3.54)
−2.37 (−8.54, 3.79)
1.05 (0.56, 2.00)
0.55 (0.32, 1.05)
0.83 (0.66, 1.05)
0.65 (−1.23, 2.54)
1.29 (−0.63, 3.20)

0.80
0.27
0.18
0.72
0.45
0.87
0.03
0.10
0.47
0.19

7.0 (5.5)
7.1 (8.4)
6.6 (6.7)
5.2 (4.1)
7.3 (5.7)
20.2 (6.2)
12.7 (29.6)

5.27 ±0.75
3.50 ± 0.63
3.81 ± 0.67
4.34 ± 0.57
5.85 ± 0.75
18.36 ± 1.11
5.81 ±0.32

4.54 ±0.76
2.36 ± 0.64
3.01 ± 0.67
3.97 ± 0.58
5.14 ± 0.77
19.15 ± 0.12
5.41 ±0.32

5.29 ±0.76
3.21 ± 0.63
3.06 ± 0.67
4.21 ± 0.58
6.09 ± 0.77
17.90 ± 1.12
5.77 ±0.32

5.20 ±0.76
3.59 ± 0.63
3.71 ± 0.67
3.89 ± 0.59
6.53 ± 0.77
18.12 ± 1.12
5.80 ±0.32

0.87 (0.71, 1.07)
0.77 (0.58, 1.02)
0.85 (0.68, 1.10)
1.10 (0.91, 1.29)
0.87 (0.68, 1.12)
1.03 (−0.23, 2.28)
0.87 (0.72, 1.05)

0.20
0.08
0.20
0.36
0.31
0.11
0.12

Values are mean ± SE., excluding norms which are presented as mean (SD) 2 Normative values of SF-36 are based on healthy adults aged 18-64 years [6]; normative values of POMS are
based on healthy adults aged ≥25 years [7], 3 Estimated marginal mean difference from linear mixed effects models, 4 Adjusted for differences between treatments, 5 Transformed variable:
Observed mean ± SE are presented together with rate ratio change in the geometric mean and associated p-value.
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4. Discussion
The current study aimed to examine the cognitive effects of a Mediterranean diet supplemented
with 2–3 weekly servings of fresh, lean pork. During the MedPork intervention, participants achieved
high adherence to the Mediterranean diet while consuming an average of 3 servings of fresh, lean
pork each day. Further, participants consumed significantly more legumes, nuts and seeds, seafood
and extra virgin olive oil. Compared with the LF control diet, the MedPork intervention led to higher
performance in the cognitive domain of processing speed and higher scores for the SF-36 subscale
emotional role functioning. No significant differences were observed for other domains of cognitive
function, nor for additional measures of psychological well-being.
Processing speed is most commonly indexed by simple and choice reaction time. Processing speed
is a marker of brain connectivity, and is integral to the coordination of higher order functions [37,38].
Further, processing speed is an indicator of cognitive aging and is a potential mediator of age-related
change across other cognitive functions [39]. Salthouse et al. proposed that changes in processing
speed could be partially responsible for age-related decline across cognitive processes that rely on
processing speed, such as memory [40,41]. Additionally, slowing in processing speed is an indicator of
mild cognitive impairment and dementia [42].
A recent publication of normative CANTAB data confirmed a positive relationship between
processing speed and age, with an increase of 0.6 ms per year in simple reaction time and an increase
of 0.9 ms per year for choice reaction time [43]. Improvements in processing speed may be capable
of attenuating these age-related declines. It is also possible that improvements to processing speed
could lead to future improvements across other cognitive domains [40,41]. Although promising, the
variability of our data must be acknowledged. Normative CANTAB data indicates a standard deviation
of ±43 ms for simple and choice reaction tests [43]. Reflected in our own results, this high level of
variability in treatment effects between subjects reduced our observed effect size. Further investigation
of the long-term effects of a Mediterranean diet on processing speed is therefore warranted.
The findings of the current study are consistent with those of a previous investigation conducted
by our research group. In the MedDairy trial, a Mediterranean diet supplemented with 3 daily
servings of dairy foods led to higher processing speed performance and mood scores over 8 weeks,
compared with a low-fat control [9]. This suggests that our positive cognitive findings are likely due
to components of the Mediterranean diet, rather than the addition of fresh pork. Few studies have
examined the association between pork and cognitive function. However, a pilot study conducted in
older, community dwelling adults reported that substituting chicken with pork did not have adverse
effects on cognitive function [18]. This is supported by the current study, which found positive cognitive
outcomes consistent with the MedDairy trial.
Observational research has indicated that the Mediterranean diet may be capable of improving
cognitive function to reduce cognitive decline and delay, or even prevent, the onset of dementia.
However, a recent meta-analysis reported that results from RCTs were predominantly non-significant,
with small effect sizes [44]. The lack of consistency across studies has been attributed to varied
methodologies and cognitive testing measures. Of the five studies included in the meta-analysis, the
robustly designed and long term PREDIMED trial (n = 1497) reported the most convincing results.
Participants following Mediterranean dietary interventions achieved greater scores on cognitive tests
of global cognition, memory and attention, compared with controls [8]. The current study design was
modelled on the PREDIMED trial, but did not detect changes across attention and memory. This may
be due to the use of different cognitive measures, although our battery of neuropsychological tests
intended to capture the same cognitive constructs as the PREDIMED trial [26]. Therefore, it is believed
that this study’s inability to elicit results similar to those observed in the PREDIMED trial may be due
the study’s duration. Specifically, the improvements observed in memory function in the PREDIMED
trial were observed over years, as opposed to weeks.
Notably, all five studies in the meta-analysis conducted by Radd-Vagenas et al. (2018) [44]
examined processing speed. However, no study found significant effects of the Mediterranean diet.
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The MedPork trial was therefore one of the first to identify significant associations between the
Mediterranean diet and processing speed. The ability of the MedPork trial to have captured these
changes could be due to the use of computerized testing, which increased the accuracy of detecting
changes measured in milliseconds.
As reported elsewhere [23], this study did not detect significant effects in cardiovascular health
following the MedPork intervention. Our findings therefore support the hypothesis that nutrients
contained within the Mediterranean diet influenced brain function directly, independent of vascular
change. For example, mono and polyunsaturated fatty acids have been identified as neuroprotective.
Specifically, long-chain omega-3 fatty acids have been found to improve white matter integrity and
processing speed [45]. Further, flavonoids and carotenoids contained within the Mediterranean diet
have been found to have antioxidant effects to preserve neural cell integrity and function, while vitamin
B12, vitamin E and folate have been found to protect against cognitive decline [29,46].
Our study also detected a significant effect of diet on emotional role functioning, a subscale of the
mental health measure assessed by the SF-36 Health Survey. Emotional role functioning encompasses
issues experienced in daily life due to emotional problems. Items in the emotional role functioning
subscale focus on whether anxiety and depression influence perceptions of work and other activities [33].
No other significant effects were found for measures of psychological well-being, although subscales
of the POMS were higher following the MedPork intervention. Notably, participant scores on the
SF-36 and POMS were within one standard deviation of the population norms. This indicates that
our sample was relatively healthy, and was thus one which may not respond to the psychological
effects of the diet Notwithstanding, our findings concerning emotional role functioning are consistent
with previous literature reporting positive associations between Mediterranean diet adherence and
quality of life in adolescent and middle-aged populations [47–50]. Further, intervention trials have
reported positive effects of the Mediterranean diet on measures of depression in middle-aged and
clinical samples [9,51,52]. As depression is a leading risk factor for dementia, future research should
continue this line of enquiry, especially in older age groups [2].
Inflammation has been implicated in the pathology of depression [53]. It has been proposed
previously that improvements to mood are due to the anti-inflammatory components of the
Mediterranean diet, such as omega-3 fatty acids [51]. Similarly, healthful dietary patterns have
been linked to improved wellbeing and a reduced risk of depression [54]. In comparison to baseline
consumption, both dietary interventions led to an increase in the consumption of fruits, vegetables and
whole grains, and reduced consumption of saturated fat. These improvements to overall diet quality
may explain the trends of higher mood and well-being scores observed across both dietary interventions.
The current study study has demonstrated that an Australian sample is capable of achieving high
adherence to a Mediterranean diet supplemented with fresh lean pork. High dietary adherence was
also observed during the LF intervention. High compliance to each intervention was likely influenced
by regular dietetic visits and the provision of food supplies during the MedPork phase. Future studies
are therefore required to determine longer-term adherence in non-clinical settings.
The MedPork trial had a number of key strengths. A parallel cross-over design was chosen
to increase the power and limit the influence of any potential differences in subject characteristics.
Dietetic counselling was delivered to promote participant understanding of, and adherence to
dietary interventions. The authors performed a comprehensive battery of cognitive tests and used a
computerised mode of cognitive testing delivered in a standardised testing environment to reduce
measurement error. The MedPork trial was also one of the first to explore the cognitive effects of pork
as part of a healthy dietary pattern.
The following limitations should also be considered. Firstly, the use of a low-fat control diet limits
the ability to appraise the differences between a Mediterranean diet supplemented with pork and
a traditional Mediterranean diet. Further, the majority of Australians do not follow a low-fat diet.
Therefore, it is unknown whether similar effects would be seen in comparison with a typical Australian
diet. It is also possible that our cognitive findings were due to a sub-optimal effect of the low-fat diet
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on brain function, as opposed to a beneficial effect of the Mediterranean diet. However, a randomised
controlled trial (RCT) of adults aged between 28 and 64 years found no significant effect of a low-fat
diet on processing speed over a period of 12 months [20]. Although our study was powered to detect
change in cognitive outcomes, the small sample size may not be reflective of the wider population
which could reduce the generalizability of our results. Further, the study duration may have limited the
capacity to detect a change in cognitive function, given that cognitive changes are likely to occur over a
number of years. Similarly, participant ages ranged between 45 and 80 years. While the sample were
at risk of CVD and therefore dementia, cognitive change may be less likely in younger participants
who have not yet experienced age-related cognitive decline. Likewise, individuals with evidence of
cognitive impairment, in whom greater cognitive change may have been observed, were excluded.
Finally, several measures, including WFRs and psychological instruments, relied on self-reporting,
which is susceptible to inaccuracies. While controlled-feeding studies offer greater accuracy, such a
controlled environment cannot be generalised to the wider population. The current study therefore
employed WFRs, the gold standard of dietary assessment, to gain comprehensive dietary intake data.
Likewise, the SF-36 and POMS were chosen due to their high validity and reliability.
The current study aimed to examine the cognitive effects of a Mediterranean diet with 2–3 weekly
servings of fresh lean pork. Our findings indicate that the MedPork intervention was capable of
improving processing speed and mood in a population at risk of CVD and therefore dementia. Our
findings provided further support for the cognitive effects of the Mediterranean diet, and the pathway
through which the diet may influence cognitive function.
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